Boehringer Ingelheim Investor

Boehringer Ingelheim is a global group of companies embracing many cultures and diverse societies.
Technology: Cell-based gene therapy, Cell_Therapies, Pharma, Whole-Cell Antigens
Industry: End-to-end Drug Development, Private, Whole-Cell Antigens
Headquarters: Ingelheim Am Rhein, Rheinland-Pfalz, Germany
Zip: NA
Founded Date: 1885-01-01
Employees Number: 10001+
Funding Status: N/A
Investor Type: Undisclosed
Investment Stage: N/A
Number Of Exits: 2
Acquisitions Number: NA
Investors Number: NA
Estimated Revenue: $1B to $10B

Visit Website
Register and Claim Ownership